Scarica l'app Stockscreener
0.0002
81.82%
-0.0009
Windtree Therapeutics Inc Borsa (WINT) Ultime notizie
Windtree Therapeutics Stock Price Forecast. Should You Buy WINT? - StockInvest.us
Windtree Therapeutics (WINT) Stock Forecast & Analyst Ratings - Moomoo
Enterprise value to revenue forward of Windtree Therapeutics, Inc. – OTC:WINT - TradingView
Windtree Therapeutics sells Seismic IP and related assets to Seismic Operations for USD 150,000 - Bitget
Windtree Therapeutics Sells Cardiovascular Portfolio, Retains Upside - TipRanks
Windtree Sells Cardiovascular Assets to Seismic; Keeps 20% Upside, $700k on $10M Financing - TradingView
Windtree Therapeutics, Inc. Actuals & Estimates (OTC:WINT) - TradingView
Windtree Therapeutics Inc (WINT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Windtree Therapeutics Inc (WINT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Windtree Therapeutics Inc (WINT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Windtree Therapeutics Inc (WINT) Institutional Confidence - TradingKey
Windtree Therapeutics Inc (WINT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Windtree Therapeutics Inc (WINT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Windtree Therapeutics Inc (WINT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Windtree Therapeutics Inc (WINT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Windtree Therapeutics Inc (WINT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Windtree Therapeutics stock (US97382D2049): what the delisting means for investors - AD HOC NEWS
TradingKey - TradingKey
WINT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
WINT | WINDTREE THERAPEUTICS NEW Insider Trading - Quiver Quantitative
Drug developer emerges in Durham with former Windtree assets - The Business Journals
Earnings Beat: Is Windtree Therapeutics Inc a strong growth stock2026 AllTime Highs & Community Trade Idea Sharing Platform - baoquankhu1.vn
Windtree Therapeutics (WINT) Eps Diluted (TTM) - Zacks Investment Research
Windtree Therapeutics Delays Filing of Annual Report - TipRanks
What analysts say about Windtree Therapeutics Inc stockPortfolio Profit Report & Daily Stock Momentum Reports - baoquankhu1.vn
Windtree (WINT) delays 2025 Form 10-K, expects to file by April 15, 2026 - Stock Titan
Windtree Therapeutics Stock: Clinical-Stage Biotech Focused on Respiratory Therapies Amid Volatile T - AD HOC NEWS
Windtree Therapeutics (WINT) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Windtree Therapeutics, Inc. (WINT) stock price, news, quote and history - Yahoo Finance Singapore
Market Moves: What analysts say about Windtree Therapeutics Inc stockTreasury Yields & Real-Time Stock Movement Alerts - baoquankhu1.vn
Windtree Therapeutics Secures $520 Million in Equity Agreements to Expand BNB Cryptocurrency Holdings - MSN
Can Windtree Therapeutics Inc sustain earnings growth2026 Short Interest & Precise Trade Entry Recommendations - baoquankhu1.vn
Earnings Beat: Is Windtree Therapeutics Inc a defensive stock2026 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Evofem (NASDAQ: EVFM) ends Windtree PHEXXI supply deal without termination fees - Stock Titan
Windtree Therapeutics Targets July for Interim Data from Key Cardiogenic Shock Study - MSN
LYRA Stock Price and Chart — OTC:LYRA - TradingView
Windtree Therapeutics Announces Promising Phase 2 Study Results for Istaroxime - MSN
CommLoan Achieves Nationwide Regulatory Approval Across All 50 States – Company Announcement - Financial Times
AI mortgage marketplace CommLoan goes nationwide, pursues reverse merger - Stock Titan
Windtree Therapeutics, Inc.Common Stock (NQ: WINT - The Chronicle-Journal
Breakout Move: What analysts say about Windtree Therapeutics Inc stock2026 EndofYear Setup & Weekly High Return Forecasts - baoquankhu1.vn
Scottsdale fintech CommLoan plans reverse merger - The Business Journals
Windtree Showcases Promising Istaroxime Data for Cardiogenic Shock at Major Conference - MSN
Aug Reactions: Is Windtree Therapeutics Incs growth already priced inQuarterly Market Summary & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Reactions: Is Windtree Therapeutics Inc stock influenced by commodity pricesFed Meeting & Verified Momentum Stock Watchlist - baoquankhu1.vn
Bearish Setup: Is Windtree Therapeutics Inc stock showing strong momentumInflation Watch & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Aug Drivers: Is Windtree Therapeutics Inc stock showing strong momentumJuly 2025 EndofMonth & Safe Entry Zone Tips - baoquankhu1.vn
Aug Macro: Is Windtree Therapeutics Inc stock showing strong momentumJuly 2025 Gainers & AI Powered Market Entry Strategies - baoquankhu1.vn
WINT Soars, DXCM Plunges, AVXL Gains: Retail Investors' Focus Premarket - Stocktwits
Windtree Therapeutics Announces Sudden Departure of President and COO - TipRanks
Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates - GlobeNewswire
Warrington’s Windtree Therapeutics Agrees to Buy Fintech Platform CommLoan - BUCKSCO.Today
Windtree Therapeutics Announces It Has Signed a Letter of - GlobeNewswire
Windtree Therapeutics issues $857,143 in convertible notes linked to CommLoan deal - Investing.com
Warrington’s Windtree Therapeutics Calls Off Acquisition of Titan Environmental Services - BUCKSCO.Today
Windtree Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - marketscreener.com
Windtree Therapeutics calls off $37M acquisition, adding to a series of failed deals - The Business Journals
Windtree Therapeutics Inc. (WINT) Stock Price | Live Quotes & Charts | EXPM - StocksToTrade
Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company - The Manila Times
0.40%
0.43%
Capitalizzazione:
|
Volume (24 ore):